T04.02.18 SWITCHING FROM INFLIXIMAB ORIGINATOR TO THE BIOSIMILAR (CT-P13) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE STUDY ABOUT EFFECTIVENESS AND SAFETY. (1st October 2020) - Annulli, G.; Quatraccioni, C.; Daretti, L.M.; Antuono, S.; Guardati, P.; Calzolari, M.; Benedetti, A.; Di Sario, A.